Open Access
- 15 November 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (11) , 3063
Abstract
The microbiota represents a key factor in determining health and disease. Its role in inflammation and immunological disorders is well known, but it is also involved in several complex conditions, ranging from neurological to psychiatric, from gastrointestinal to cardiovascular diseases. It has recently been hypothesized that the gut microbiota may act as an intermediary in the close interaction between kidneys and the cardiovascular system, leading to the conceptualization of the “gut–kidney–heart” axis. In this narrative review, we will discuss the impact of the gut microbiota on each system while also reviewing the available data regarding the axis itself. We will also describe the role of gut metabolites in this complex interplay, as well as potential therapeutical perspectives.Keywords
This publication has 187 references indexed in Scilit:
- The intestinal microbiota, a leaky gut, and abnormal immunity in kidney diseaseKidney International, 2013
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- The Purine-Utilizing Bacterium Clostridium acidurici 9a: A Genome-Guided Metabolic ReconsiderationPLOS ONE, 2012
- Intestinal microbiota determine severity of myocardial infarction in ratsThe FASEB Journal, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Mucin dynamics and enteric pathogensNature Reviews Microbiology, 2011
- Uremic toxins originating from colonic microbial metabolismKidney International, 2009
- Barrier-protective function of intestinal epithelial Toll-like receptor 2Mucosal Immunology, 2008
- The bacterial superantigen and superantigen‐like proteinsImmunological Reviews, 2008
- The intestinal immune system.Gut, 1989